Enhancing Operational Efficiency, Advancing with Long-Term Commitment | 2026 New Year Message from Sun Pengfei, President of Linuo

Pharmaceutical Packaging
Brand Center | LINUO Pharmaceutical Packaging

Dear Investors, Partners, and Colleagues,

As the new year begins, everything takes on a fresh look. With 2026 just around the corner, on behalf of the management team of Shandong Linuo Pharmaceutical Packaging Co., Ltd., I would like to extend my deepest gratitude and warmest New Year wishes to all investors, global partners, and every employee who has continuously supported and contributed to our growth.

2025 marked the 30th anniversary of the company’s establishment. With a renewed vision of “Thirty Years of Strength, Embarking on a New Journey,” Linuo Pharmaceutical Packaging actively responded to profound global economic and industrial transformations. From strategy to execution, from intelligent manufacturing to global expansion, we have been committed to building a more resilient, efficient, and sustainable growth model.

Strategic Focus | Advancing with Stability

Linuo Pharmaceutical Packaging has consistently adhered to the strategic principle of “focusing on pharmaceutical packaging as our core development direction,” continuously deepening our core business and optimizing resource allocation.

In 2025, the second furnace of the Lightweight Pharmaceutical Molded Glass Bottle (Type I) Industrialization Project was successfully ignited and put into operation, further strengthening our core production capacity. Our Dual-Chamber Cartridge won the Design Champion Award, while the PFS & RTU high-end pharmaceutical packaging product series officially launched smart factory construction and completed its global release. These achievements demonstrate our transition from technology follower to industry standard leader.

Intelligent Manufacturing | Improving Quality and Efficiency

Intelligent manufacturing represents a critical pathway for addressing quality, efficiency, and cost challenges in the pharmaceutical packaging industry.

In 2025, Linuo Pharmaceutical Packaging’s investments in intelligent manufacturing gradually translated into tangible operational results. More than 420,000 high-quality data assets were successfully recognized and incorporated into our asset management system, driving data governance toward greater standardization and intelligence.

As the first company in the industry to achieve CMMM Level 4 certification, Linuo Pharmaceutical Packaging is steadily moving toward the goal of becoming the pharmaceutical packaging industry’s first “Lighthouse Factory.”

Based on our deep understanding of high-temperature manufacturing environments within the industry, our wholly owned subsidiary, Shandong Linuo Intelligent Robot Co., Ltd., has transformed intelligent capabilities into market-oriented products, targeting the creation of our second growth curve.

Global Expansion | Collaborative Growth

In 2025, Linuo Pharmaceutical Packaging entered a new phase of global expansion featuring “deep local engagement and ecosystem collaboration.”

In China, through the acquisition of equity in Suzhou Chuangyang New Materials, we strengthened our plastic packaging capabilities and established an integrated “glass + plastic” one-stop service model, enhancing customer value and supply chain competitiveness.

Overseas, we established strategic partnerships with renowned companies such as Brazilian SANTISA and U.S.-based Xseer, achieving a transformation from “Made in China” to “Global Operations.” These initiatives have enhanced our local service capabilities, risk resilience, international influence, and industry competitiveness.

“Brand + Technology” | Dual Upgrade

In 2025, Linuo Pharmaceutical Packaging actively promoted the transformation of its heat-resistant glass business toward independent branding. Domestically, we launched “LEBOLEBO,” while internationally we introduced “BOROHOUSE.” Meanwhile, we established an e-commerce company in Hangzhou to operate independently, gradually advancing our transformation from OEM to ODM and OBM.

At the same time, Linuo Pharmaceutical Packaging established provincial-level laboratories in cooperation with universities. The officially launched testing and research center, accredited by CNAS, further strengthened our technological foundation while laying the groundwork for participation in industry standard development and expansion into professional testing services.

Looking Ahead | Embarking on a New Chapter in 2026

2026 marks the beginning of the 15th Five-Year Plan period. While challenges and opportunities coexist, we remain fully confident.

This confidence comes from our solid technological foundation built through 30 years of dedicated industry experience, from the enhanced competitiveness created by intelligent manufacturing and global strategic deployment, and from our commitment to long-term thinking and disciplined, sustainable operations.

We believe that over the next thirty years, supported by clear strategic planning, an efficient execution team, and the continued trust of our partners, Linuo Pharmaceutical Packaging will continue to overcome market cycles, achieve steady and sustainable growth, and work together with global partners to build an outstanding brand in the pharmaceutical packaging industry.

May the new year bring everyone good health, greater achievements in your careers, happiness for your families, and success in all endeavors!

2026 — Embrace the Dragon Spirit · Moving Forward Together

HAPPY NEW YEAR

Produced by | Brand Center
Text & Layout | Qi Jinlong
Image Source | Li Jiakai
Editor in Charge | Mei Jinjiao